These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials. Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782 [TBL] [Abstract][Full Text] [Related]
4. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models. Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265 [TBL] [Abstract][Full Text] [Related]
6. Hurdles for the wide implementation of photoimmunotherapy. Matsuoka K; Sato M; Sato K Immunotherapy; 2021 Dec; 13(17):1427-1438. PubMed ID: 34693721 [TBL] [Abstract][Full Text] [Related]
7. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Ogawa M; Tomita Y; Nakamura Y; Lee MJ; Lee S; Tomita S; Nagaya T; Sato K; Yamauchi T; Iwai H; Kumar A; Haystead T; Shroff H; Choyke PL; Trepel JB; Kobayashi H Oncotarget; 2017 Feb; 8(6):10425-10436. PubMed ID: 28060726 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model. Okada R; Furusawa A; Inagaki F; Wakiyama H; Kato T; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H Cancer Sci; 2021 Aug; 112(8):3041-3049. PubMed ID: 34101947 [TBL] [Abstract][Full Text] [Related]
9. Near infrared photoimmunotherapy for cancers: A translational perspective. Maruoka Y; Wakiyama H; Choyke PL; Kobayashi H EBioMedicine; 2021 Aug; 70():103501. PubMed ID: 34332294 [TBL] [Abstract][Full Text] [Related]
10. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy. Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765 [TBL] [Abstract][Full Text] [Related]
11. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700. Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415 [TBL] [Abstract][Full Text] [Related]
12. [Near Infrared Photoimmunotherapy for Cancer]. Kobayashi H Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637 [TBL] [Abstract][Full Text] [Related]
13. Near infrared photoimmunotherapy of cancer; possible clinical applications. Wakiyama H; Kato T; Furusawa A; Choyke PL; Kobayashi H Nanophotonics; 2021 Sep; 10(12):3135-3151. PubMed ID: 36405499 [TBL] [Abstract][Full Text] [Related]
14. Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors. Nagaya T; Friedman J; Maruoka Y; Ogata F; Okuyama S; Clavijo PE; Choyke PL; Allen C; Kobayashi H Cancer Immunol Res; 2019 Mar; 7(3):401-413. PubMed ID: 30683733 [TBL] [Abstract][Full Text] [Related]
15. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers. Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869 [TBL] [Abstract][Full Text] [Related]
17. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response. Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486 [TBL] [Abstract][Full Text] [Related]
18. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor. Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062 [TBL] [Abstract][Full Text] [Related]
19. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723 [TBL] [Abstract][Full Text] [Related]